Fiorella D’Auria

1.3k total citations
42 papers, 674 citations indexed

About

Fiorella D’Auria is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Fiorella D’Auria has authored 42 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 19 papers in Hematology and 16 papers in Oncology. Recurrent topics in Fiorella D’Auria's work include Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (14 papers) and Multiple Myeloma Research and Treatments (12 papers). Fiorella D’Auria is often cited by papers focused on Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (14 papers) and Multiple Myeloma Research and Treatments (12 papers). Fiorella D’Auria collaborates with scholars based in Italy, Japan and United States. Fiorella D’Auria's co-authors include Pellegrino Musto, Giovanni D’Arena, Vittorio Simeon, Giuseppe Pietrantuono, Giovanna Mansueto, Francesco La Rocca, Teodora Statuto, Ilaria Laurenzana, Luigi Del Vecchio and Luciana De Luca and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Fiorella D’Auria

36 papers receiving 665 citations

Peers

Fiorella D’Auria
Hua Dong China
Na Luo China
Andrew Yen United States
Tong Sun United States
Manoj M. Pillai United States
Hua Dong China
Fiorella D’Auria
Citations per year, relative to Fiorella D’Auria Fiorella D’Auria (= 1×) peers Hua Dong

Countries citing papers authored by Fiorella D’Auria

Since Specialization
Citations

This map shows the geographic impact of Fiorella D’Auria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiorella D’Auria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiorella D’Auria more than expected).

Fields of papers citing papers by Fiorella D’Auria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiorella D’Auria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiorella D’Auria. The network helps show where Fiorella D’Auria may publish in the future.

Co-authorship network of co-authors of Fiorella D’Auria

This figure shows the co-authorship network connecting the top 25 collaborators of Fiorella D’Auria. A scholar is included among the top collaborators of Fiorella D’Auria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiorella D’Auria. Fiorella D’Auria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Arena, Giovanni, Candida Vitale, Giuseppe Pietrantuono, et al.. (2024). What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. Cancers. 16(2). 469–469. 3 indexed citations
2.
D’Auria, Fiorella, Giovanni Calice, Vittoria D’Esposito, et al.. (2024). Hypofractionated radiotherapy with simultaneous integrated boost for localized prostate cancer patients: effects on immune system and prediction of toxicity. Frontiers in Immunology. 15. 1457839–1457839.
3.
D’Arena, Giovanni, Fiorella D’Auria, Luciana De Luca, et al.. (2023). Preliminary analysis of double‐negative T, double‐positive T, and natural killer T‐like cells in B‐cell chronic lymphocytic leukemia. Cancer Medicine. 12(12). 13241–13255. 5 indexed citations
4.
D’Auria, Fiorella, Vitina Grieco, Teodora Statuto, et al.. (2022). Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association. Frontiers in Oncology. 12. 1069977–1069977.
5.
D’Arena, Giovanni, Alessandro Sgambato, Giuseppe Coppola, et al.. (2022). Flow cytometric evaluation of measurable residual disease in chronic lymphocytic leukemia: Where do we stand?. Hematological Oncology. 40(5). 835–842. 2 indexed citations
6.
D’Arena, Giovanni, Vincenzo De Feo, Giuseppe Pietrantuono, et al.. (2020). CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance. Frontiers in Oncology. 10. 584427–584427. 20 indexed citations
7.
Statuto, Teodora, Fiorella D’Auria, Luigi Del Vecchio, et al.. (2020). <p>Atypical Mature T-Cell Neoplasms: The Relevance of the Role of Flow Cytometry</p>. OncoTargets and Therapy. Volume 13. 7605–7614. 2 indexed citations
8.
Romano, Alessandra, Nunziatina Laura Parrinello, Vittorio Simeon, et al.. (2020). High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling. Scientific Reports. 10(1). 1983–1983. 42 indexed citations
9.
Statuto, Teodora, Giovanni Calice, Oreste Villani, et al.. (2019). Cytofluorimetric and immunohistochemical comparison for detecting bone marrow infiltration in non-Hodgkin lymphomas: a study of 354 patients. Leukemia Research. 88. 106267–106267. 7 indexed citations
10.
Musto, Pellegrino, et al.. (2019). An update on biology, diagnosis and treatment of primary plasma cell leukemia. Expert Review of Hematology. 12(4). 245–253. 16 indexed citations
11.
Caivano, Antonella, Ilaria Laurenzana, Luciana De Luca, et al.. (2015). High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumor Biology. 36(12). 9739–9752. 149 indexed citations
12.
Condelli, Valentina, Giacomo Lettini, Fiorella D’Auria, et al.. (2014). Validation of Vacuum-Based Refrigerated System for Biobanking Tissue Preservation: Analysis of Cellular Morphology, Protein Stability, and RNA Quality. Biopreservation and Biobanking. 12(1). 35–45. 13 indexed citations
13.
Petruzziello, Fara, Pio Zeppa, Giuseppe Ciancia, et al.. (2011). Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myeloma. Leukemia & lymphoma. 52(12). 2304–2307. 17 indexed citations
14.
Musto, Pellegrino, Livio Pagano, Maria Teresa Petrucci, et al.. (2011). Primary plasma cell leukemia in the era of new drugs: Has something changed?. Critical Reviews in Oncology/Hematology. 82(2). 141–149. 13 indexed citations
15.
Musto, Pellegrino & Fiorella D’Auria. (2011). The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders. Expert Opinion on Biological Therapy. 11(5). 551–557. 11 indexed citations
16.
Guariglia, Roberto, Maria Carmen Martorelli, Oreste Villani, et al.. (2010). Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: A brief review. Leukemia Research. 35(5). 566–570. 50 indexed citations
17.
Moschetta, Michele, Giulia Di Pietro, Roberto Ria, et al.. (2009). Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. European Journal of Cancer. 46(2). 420–429. 51 indexed citations
18.
Musto, Pellegrino, Fiorella D’Auria, Giuseppe Pietrantuono, et al.. (2009). First-Line Treatment of Multiple Myeloma in Elderly Patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dellAdulto) Multiple Myeloma Working Party Perspective. Current Drug Targets. 10(10). 906–922. 5 indexed citations
19.
Musto, Pellegrino, Fiorella D’Auria, Giuseppe Pietrantuono, et al.. (2008). Role of thalidomide in previously untreated patients with multiple myeloma. Expert Review of Anticancer Therapy. 8(10). 1569–1580. 4 indexed citations
20.
Musto, Pellegrino & Fiorella D’Auria. (2007). Melphalan: old and new uses of a still master drug for multiple myeloma. Expert Opinion on Investigational Drugs. 16(9). 1467–1487. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026